ATG10 overexpression has been associated with poor prognosis and adverse clinicopathological features in gastric cancer, colorectal cancer and acute leukemia, as determined by RT-PCR, immunohistochemistry and western blotting (Table 4). The gene discussed is ATG10; the disease is gastric cancer.